Toxoplasmosis medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:
{{CMG}}
{{CMG}}
==Medical Therapy==
==Medical Therapy==
Teatment is not needed for a healthy person who is not pregnant. Symptoms will usually go away within a few weeks.  Treatment may be recommended for pregnant women or persons who have weakened immune systems <ref>http://www.dpd.cdc.gov/dpdx/HTML/Toxoplasmosis.htm</ref>.  
==Overveiw==
 
===Antimicrobial Regimen===
=== Pharmacotherapy ===
:* Toxoplasma gondii (treatment)
 
::* 1. '''Lymphadenopathic toxoplasmosis'''<ref>{{ cite web | title = Parasites - Toxoplasmosis (Toxoplasma infection) |  url = http://www.cdc.gov/parasites/toxoplasmosis/health_professionals/ }}</ref>
Medications that are prescribed for acute Toxoplasmosis are:
:::* Preferred regimen: Treatment of immunocompetent adults with lymphadenopathic toxoplasmosis is rarely indicated; this form of the disease is usually self-limited.
* [[Pyrimethamine]] &mdash; an [[antimalarial medication]].
::* 2. '''Ocular disease'''<ref>{{ cite web | title = Parasites - Toxoplasmosis (Toxoplasma infection) |  url = http://www.cdc.gov/parasites/toxoplasmosis/health_professionals/ }}</ref>
* [[Sulfadiazine]] &mdash; an [[antibiotic]] used in combination with pyrimethamine to treat toxoplasmosis.
:::* 2.1 '''Adults'''
* [[clindamycin]] &mdash; an antibiotic. This is used most often for people with HIV/AIDS.
::::* Preferred regimen: [[Pyrimethamine]] 100 mg PO for 1 day as a loading dose, then 25 to 50 mg/day {{and}} [[Sulfadiazine]] 1 g PO qid {{and}} folinic acid ([[Leucovorin]] 5-25 mg PO with each dose of [[Pyrimethamine]]
* [[spiramycin]] &mdash; another antibiotic. This is used most often for pregnant women to prevent the infection of their child.  
:::* 2.2 '''Pediatric'''
 
::::* Preferred regimen: [[Pyrimethamine]] 2 mg/kg PO first day then 1 mg/kg each day {{and}} [[Sulfadiazine]] 50 mg/kg PO bid {{and}} folinic acid ([[Leucovorin]] 7.5 mg/day PO ) for 4 to 6 weeks followed by reevaluation of the patient's condition
(Other antibiotics such as [[minocycline]] have seen some use as a salvage therapy).
::::* Alternative regimen: The fixed combination of [[Trimethoprim]] with [[Sulfamethoxazole]] has been used as an alternative.
 
::::* Note: If the patient has a hypersensitivity reaction to sulfa drugs, [[Pyrimethamine]] {{and}}  [[Clindamycin]] can be used instead.
Medications that are prescribed for latent Toxoplasmosis are:
::* 3. '''Maternal and fetal infection'''<ref>{{ cite web | title = Parasites - Toxoplasmosis (Toxoplasma infection) |  url = http://www.cdc.gov/parasites/toxoplasmosis/health_professionals/ }}</ref>
* [[atovaquone]] &mdash; an antibiotic that has been used to kill Toxoplasma cysts in situ in [[AIDS]] patients. <ref>
:::* 3.1 '''First and early second trimesters'''
{{cite web | title=Toxoplasmosis - treatment key research | url=http://www.aidsmap.com/en/docs/659BAD5D-332A-4F8D-9F93-8D0F470B2D32.asp | date=2005-11-02 | publisher=NAM & aidsmap}}</ref>
::::* Preferred regimen: [[Spiramycin]] is recommended
* [[clindamycin]] &mdash; an antibiotic which, in combination with atovaquone, seemed to optimally kill cysts in mice.<ref>
:::* 3.2 '''Late second and third trimesters'''
{{cite journal | author = Djurković-Djaković O, Milenković V, Nikolić A, Bobić B, Grujić J | title = Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii. | journal = J Antimicrob Chemother | volume = 50 | issue = 6 | pages = 981-7 | year = 2002 | id = PMID 12461021 | doi = 10.1093/jac/dkf251 | url=http://jac.oxfordjournals.org/cgi/reprint/50/6/981.pdf | format=PDF}}</ref>
::::* Preferred regimen: [[Pyrimethamine]]/[[ Sulfadiazine]] {{and}} [[Leucovorin]] for women with acute T. gondii infection diagnosed at a reference laboratory during gestation.
 
:::* 3.3 '''Infant'''
However, in latent infections successful treatment is not guaranteed, and some subspecies exhibit resistance.
::::* Note: If the infant is likely to be infected, then treatment with drugs such as [[Pyrimethamine]], [[Atovaquone]], [[Sulfadiazine]], [[Leucovorin]]  is typical. Congenitally infected newborns are generally treated with [[pyrimethamine]], a sulfonamide, and [[leucovorin]] for 1 year.
::* 4. '''Toxoplasma gondii Encephalitis in AIDS'''<ref>{{ cite web | title = Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents  | url = https://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultOITablesOnly.pdf }}</ref>
:::* 4.1 '''Treatment for acute infection'''
::::* 4.1.1 '''Patients with weight <60 kg'''
::::* Preferred regimen: [[Pyrimethamine]] 200 mg PO 1 time, followed by [[Pyrimethamine]] 50 mg PO qd {{and}} [[Atovaquone]] {{and}} [[Sulfadiazine]] 1000 mg PO q6h {{and}} [[Leucovorin]] 10–25 mg PO qd,
::::* 4.1.2  '''Patients with weight ≥60 kg'''
:::::* Preferred regimen: [[Pyrimethamine]] 200 mg PO 1 time, followed by [[Pyrimethamine]] 75 mg PO qd {{and}} [[Sulfadiazine]] 1500 mg PO q6h {{and}} [[Leucovorin]] 10–25 mg PO qd and [[Leucovorin]] dose can be increased to 50 mg qd or bid
:::::* Alternative regimen (1): [[Pyrimethamine]] {{and}} [[Leucovorin]] {{and}} [[Clindamycin]] 600 mg IV/ PO q6h
:::::* Alternative regimen (2): [[TMP-SMX]] (TMP 5 mg/kg and SMX 25 mg/kg ) IV/PO bid
:::::* Alternative regimen (3): [[Atovaquone]] 1500 mg PO bid {{and}} [[Pyrimethamine]] {{and}} [[Leucovorin]]
:::::* Alternative regimen (4): [[Atovaquone]]1500 mg PO bid {{and}} [[sulfadiazine]] 1000–1500 mg PO q6h (weight-based dosing, as in preferred therapy)
:::::* Alternative regimen (5): [[Atovaquone]] 1500 mg PO bid
:::::* Alternative regimen (6): [[Pyrimethamine]] {{and}} [[Leucovorin]] {{and}} [[Azithromycin]] 900–1200 mg PO qd
:::::* Note: Treatment for at least 6 weeks; longer duration if clinical or radiologic disease is extensive or response is incomplete at 6 weeks.
:::* 4.2  '''Chronic maintenance therapy'''
::::* Preferred regimen:  [[Pyrimethamine]] 25–50 mg PO qd {{and}} [[sulfadiazine]] 2000–4000 mg PO qd (in 2–4 divided doses) {{and}} [[Leucovorin]] 10–25 mg PO qd
::::* Alternative regimen (1): [[Clindamycin]] 600 mg PO q8h {{and}} ([[Pyrimethamine]] 25–50 mg {{and}} [[Leucovorin]] 10–25 mg) PO qd
::::* Alternative regimen (2): [[TMP-SMX]] DS 1 tablet bid
::::* Alternative regimen (3): [[Atovaquone]] 750–1500 mg PO bid {{and}} ([[Pyrimethamine]] 25 mg {{and}} [[Leucovorin]] 10 mg) PO qd
::::* Alternative regimen (4): [[Atovaquone]] 750–1500 mg PO bid
::::* Alternative regimen (5): [[Sulfadiazine]] 2000–4000 mg PO bid/qid
::::* Alternative regimen (6): [[Atovaquone]] 750–1500 mg PO bid [[Pyrimethamine]] and [[Leucovorin]] doses are the same as for preferred therapy
::::* Note: Adjunctive corticosteroids (e.g., [[Dexamethasone]]) should only be administered when clinically indicated to treat mass effect associated with focal lesions or associated edema; discontinue as soon as clinically feasible. Anticonvulsants should be administered to patients with a history of seizures and continued through acute treatment, but should not be used as seizure prophylaxis . If [[Clindamycin]] is used in place of [[Sulfadiazine]], additional therapy must be added to prevent PCP.
:* '''Toxoplasma gondii (prophylaxis)'''
::* 1. '''Prophylaxis to prevent first episode of encephalitis in AIDS'''<ref>{{ cite web | title = Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents  | url = https://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultOITablesOnly.pdf }}</ref>
:::* 1.1 '''Indications'''
::::* Toxoplasma IgG-positive patients with CD4 count <100 cells/µL
::::* Seronegative patients receiving PCP prophylaxis not active against toxoplasmosis should have toxoplasma serology retested if CD4 count decline to <100 cells/µL. Prophylaxis should be initiated if seroconversion occurred.
:::* 1.2 '''Prophylactic therapy'''
::::* Preferred regimen: [[TMP-SMX]] 1 DS PO daily
::::* Alternative regimen (1): [[TMP-SMX]] 1 DS PO three times weekly
::::* Alternative regimen (2): [[TMP-SMX]] 1 SS PO qd
::::* Alternative regimen (3): [[Dapsone]] 50 mg PO qd {{and}} ([[Pyrimethamine]] 50 mg PO {{and}} [[Leucovorin]] 25 mg) PO weekly
::::* Alternative regimen (4): [[Dapsone]] 200 mg PO {{and}} [[Pyrimethamine]] 75 mg PO {{and}} [[Leucovorin]] 25 mg PO weekly 
::::* Alternative regimen (5): [[Atovaquone]] 1500 mg PO qd
::::* Alternative regimen (6): [[Atovaquone]] 1500 mg  PO {{and}} [[Pyrimethamine]] 25 mg PO {{and}} [[Leucovorin]] 10 mg PO qd


==References==
==References==

Revision as of 03:01, 8 August 2015

Toxoplasmosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxoplasmosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxoplasmosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxoplasmosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxoplasmosis medical therapy

CDC on Toxoplasmosis medical therapy

Toxoplasmosis medical therapy in the news

Blogs on Toxoplasmosis medical therapy

Directions to Hospitals Treating Toxoplasmosis

Risk calculators and risk factors for Toxoplasmosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical Therapy

Overveiw

Antimicrobial Regimen

  • Toxoplasma gondii (treatment)
  • 1. Lymphadenopathic toxoplasmosis[1]
  • Preferred regimen: Treatment of immunocompetent adults with lymphadenopathic toxoplasmosis is rarely indicated; this form of the disease is usually self-limited.
  • 2. Ocular disease[2]
  • 2.1 Adults
  • 2.2 Pediatric
  • Preferred regimen: Pyrimethamine 2 mg/kg PO first day then 1 mg/kg each day AND Sulfadiazine 50 mg/kg PO bid AND folinic acid (Leucovorin 7.5 mg/day PO ) for 4 to 6 weeks followed by reevaluation of the patient's condition
  • Alternative regimen: The fixed combination of Trimethoprim with Sulfamethoxazole has been used as an alternative.
  • Note: If the patient has a hypersensitivity reaction to sulfa drugs, Pyrimethamine AND Clindamycin can be used instead.
  • 3. Maternal and fetal infection[3]
  • 3.1 First and early second trimesters
  • 3.2 Late second and third trimesters
  • 3.3 Infant
  • 4. Toxoplasma gondii Encephalitis in AIDS[4]
  • 4.1 Treatment for acute infection
  • 4.2 Chronic maintenance therapy
  • Preferred regimen: Pyrimethamine 25–50 mg PO qd AND sulfadiazine 2000–4000 mg PO qd (in 2–4 divided doses) AND Leucovorin 10–25 mg PO qd
  • Alternative regimen (1): Clindamycin 600 mg PO q8h AND (Pyrimethamine 25–50 mg AND Leucovorin 10–25 mg) PO qd
  • Alternative regimen (2): TMP-SMX DS 1 tablet bid
  • Alternative regimen (3): Atovaquone 750–1500 mg PO bid AND (Pyrimethamine 25 mg AND Leucovorin 10 mg) PO qd
  • Alternative regimen (4): Atovaquone 750–1500 mg PO bid
  • Alternative regimen (5): Sulfadiazine 2000–4000 mg PO bid/qid
  • Alternative regimen (6): Atovaquone 750–1500 mg PO bid Pyrimethamine and Leucovorin doses are the same as for preferred therapy
  • Note: Adjunctive corticosteroids (e.g., Dexamethasone) should only be administered when clinically indicated to treat mass effect associated with focal lesions or associated edema; discontinue as soon as clinically feasible. Anticonvulsants should be administered to patients with a history of seizures and continued through acute treatment, but should not be used as seizure prophylaxis . If Clindamycin is used in place of Sulfadiazine, additional therapy must be added to prevent PCP.
  • Toxoplasma gondii (prophylaxis)
  • 1. Prophylaxis to prevent first episode of encephalitis in AIDS[5]
  • 1.1 Indications
  • Toxoplasma IgG-positive patients with CD4 count <100 cells/µL
  • Seronegative patients receiving PCP prophylaxis not active against toxoplasmosis should have toxoplasma serology retested if CD4 count decline to <100 cells/µL. Prophylaxis should be initiated if seroconversion occurred.
  • 1.2 Prophylactic therapy

References

  1. "Parasites - Toxoplasmosis (Toxoplasma infection)".
  2. "Parasites - Toxoplasmosis (Toxoplasma infection)".
  3. "Parasites - Toxoplasmosis (Toxoplasma infection)".
  4. "Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents" (PDF).
  5. "Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents" (PDF).


Template:WikiDoc Sources